Results of defocus curve testing in eyes with a refractive multifocal IOL implanted as part of a prospective, multicenter comparative trial are better for the +3-D near-add version of the lens compared with the +4-D near-add platform with regard to intermediate visual acuity.
Cheryl Guttman Krader
You might be reluctant to fit more children in contact lenses into your optical dispensary because you think it's difficult and time-consuming. However, the extra chair time is minimal, and the final rewards for the patient, the family, and you can be great, especially when contact lenses are medically necessary.
Results of a preclinical study demonstrate the feasibility of implanting a next-generation injectable version of a telescope prosthesis for end-stage macular degeneration and suggest it has promising advantages for improving surgical ease and safety.
On April 20, Abbott Medical Optics announced that it had received FDA clearance for use of the 150-kHz iFS advanced femtosecond laser to create arcuate incisions during corneal surgery, including cataract surgery.
Leading refractive surgeons agree wavefront-guided ablation is a significant advance in laser vision correction, but have different opinions about its role in treating myopic eyes with low higher-order aberrations.
Understanding the cause of elevated IOP in patients with uveitis is the basis for developing a rational treatment plan.
As outgoing president of the ASCRS, Edward J. Holland, MD, can be recognized for a number of accomplishments and the introduction of several new initiatives.
Many agents have been investigated in clinical trials for neuroprotection in glaucoma, but none has proven efficacy, and so IOP control continues to be the mainstay strategy for preventing glaucoma progression.
Results from randomized controlled clinical trials investigating populations covering the spectrum from ocular hypertension to advanced glaucoma provide clear evidence that for most patients, glaucoma is an IOP-sensitive optic neuropathy for which lowering IOP is effective in slowing or arresting progression.
The world of glaucoma management in 2012 is feeling the impact of not only a variety of challenges, but also new opportunities.